Clinical Trial Update: Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating normobaric hyperoxia combined with endovascular treatment for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Acute

Snippet

Sponsor: Capital Medical University | Conditions: Stroke, Acute, Neuroprotection | Phase 2 | Status: COMPLETED